Miyuki Sakuma, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophil Infiltration | 1 | 2019 | 393 | 0.550 |
Why?
|
| Sciatic Nerve | 3 | 2021 | 628 | 0.530 |
Why?
|
| Neuromuscular Junction | 1 | 2015 | 407 | 0.420 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2219 | 0.380 |
Why?
|
| Neutrophils | 3 | 2022 | 3786 | 0.370 |
Why?
|
| Nerve Regeneration | 2 | 2021 | 797 | 0.370 |
Why?
|
| Motor Neurons | 1 | 2015 | 870 | 0.350 |
Why?
|
| Osteoclasts | 2 | 2020 | 713 | 0.310 |
Why?
|
| Burns | 1 | 2019 | 1899 | 0.290 |
Why?
|
| Sepsis | 1 | 2022 | 2608 | 0.290 |
Why?
|
| Pneumonia | 1 | 2019 | 2163 | 0.290 |
Why?
|
| Hindlimb Suspension | 1 | 2005 | 76 | 0.230 |
Why?
|
| Bone Marrow Cells | 3 | 2008 | 2414 | 0.220 |
Why?
|
| Parathyroidectomy | 1 | 2005 | 244 | 0.210 |
Why?
|
| DNA Breaks | 1 | 2021 | 47 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2020 | 547 | 0.190 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2021 | 108 | 0.190 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2021 | 62 | 0.180 |
Why?
|
| Peripheral Nervous System | 1 | 2018 | 151 | 0.140 |
Why?
|
| Sensory Receptor Cells | 1 | 2021 | 508 | 0.130 |
Why?
|
| Microfluidics | 1 | 2022 | 672 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2020 | 11669 | 0.130 |
Why?
|
| Denervation | 1 | 2015 | 265 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2005 | 2589 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2005 | 2479 | 0.110 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 1430 | 0.110 |
Why?
|
| Axons | 1 | 2021 | 1677 | 0.110 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 836 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 1398 | 0.100 |
Why?
|
| Spondylolysis | 1 | 2002 | 46 | 0.100 |
Why?
|
| Facies | 1 | 2002 | 224 | 0.090 |
Why?
|
| Mice | 9 | 2022 | 82029 | 0.090 |
Why?
|
| Toes | 1 | 2002 | 209 | 0.090 |
Why?
|
| Chromatin | 1 | 2022 | 2981 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 22379 | 0.080 |
Why?
|
| Fingers | 1 | 2002 | 511 | 0.080 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2008 | 305 | 0.070 |
Why?
|
| Animals | 9 | 2022 | 169246 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2015 | 2981 | 0.060 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 79 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 1 | 2008 | 363 | 0.060 |
Why?
|
| Angiopoietin-1 | 1 | 2005 | 133 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 8128 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2005 | 179 | 0.060 |
Why?
|
| Angiopoietin-2 | 1 | 2005 | 186 | 0.050 |
Why?
|
| Phosphorus | 1 | 2005 | 336 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2005 | 1084 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2005 | 321 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 587 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2002 | 1885 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 863 | 0.050 |
Why?
|
| Bone Development | 1 | 2005 | 473 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2020 | 19015 | 0.050 |
Why?
|
| Adipocytes | 1 | 2008 | 1197 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2005 | 1340 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 859 | 0.040 |
Why?
|
| Organ Size | 1 | 2005 | 2267 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2005 | 1145 | 0.040 |
Why?
|
| Rats | 1 | 2015 | 23760 | 0.040 |
Why?
|
| Tibia | 1 | 2005 | 1076 | 0.040 |
Why?
|
| Temperature | 1 | 2005 | 2234 | 0.040 |
Why?
|
| Gene Expression | 2 | 2021 | 7598 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2020 | 393 | 0.040 |
Why?
|
| Blood Donors | 1 | 2020 | 343 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4580 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 1369 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2937 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2202 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2022 | 1530 | 0.030 |
Why?
|
| Stem Cells | 2 | 2008 | 3537 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 529 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5902 | 0.030 |
Why?
|
| Body Weight | 1 | 2005 | 4627 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3711 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1854 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4427 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3589 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2005 | 4937 | 0.020 |
Why?
|
| Calcium | 1 | 2005 | 5792 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 2011 | 0.020 |
Why?
|
| Male | 5 | 2018 | 364719 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2005 | 12800 | 0.020 |
Why?
|
| Cytokines | 1 | 2005 | 7453 | 0.020 |
Why?
|
| Tibial Fractures | 1 | 2002 | 276 | 0.020 |
Why?
|
| Macrophages | 1 | 2022 | 5799 | 0.020 |
Why?
|
| Syndrome | 1 | 2002 | 3272 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9561 | 0.020 |
Why?
|
| Humans | 4 | 2022 | 768166 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40218 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10873 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 1804 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2008 | 1288 | 0.010 |
Why?
|
| Radiography | 1 | 2002 | 6983 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2008 | 4176 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10474 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9495 | 0.010 |
Why?
|
| Female | 2 | 2018 | 397192 | 0.000 |
Why?
|
| Adult | 1 | 2002 | 223646 | 0.000 |
Why?
|